Molecular Imaging and Radionuclide Therapy (formerly Turkish Journal of Nuclear Medicine) is the official publication of Turkish Society of Nuclear Medicine.
Focus and Scope
Molecular Imaging and Radionuclide Therapy (Mol Imaging Radionucl Ther, MIRT) is a double-blind peer-review journal published in English language. It publishes original research articles, reviews, editorials, short communications, letters, consensus statements, guidelines and case reports with a literature review on the topic, in the field of molecular imaging, multimodality imaging, nuclear medicine, radionuclide therapy, radiopharmacy, medical physics, dosimetry and radiobiology. MIRT is published three times a year (February, June, October). Audience: Nuclear medicine physicians, medical physicists, radiopharmaceutical scientists, radiobiologists.
The editorial policies are based on the “Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals (ICMJE Recommendations)” by the International Committee of Medical Journal Editors (2016, archived at http://www.icmje.org/) rules.
Molecular Imaging and Radionuclide Therapy is indexed in Pubmed, Pubmed Central (PMC), Emerging Sources Citation Index (ESCI), TUBITAK-ULAKBIM, Scopus, Gale/Cengage Learning, EBSCO databases, ProQuest Health & Medical Complete, CINAHL, DOAJ, British Library, Türkiye Atıf Dizini (Türkiye Citation Index), Turk Medline.
This version of MIRT Android App comes with one universal variant which will work on all the Android devices.
If you are looking to download other versions of MIRT Android App, We have 1 version in our database. Please select one of them below to download.